Free Trial

Nomura Asset Management Co. Ltd. Sells 7,851 Shares of Waters Co. (NYSE:WAT)

Waters logo with Medical background

Nomura Asset Management Co. Ltd. lessened its stake in Waters Co. (NYSE:WAT - Free Report) by 26.2% in the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 22,082 shares of the medical instruments supplier's stock after selling 7,851 shares during the period. Nomura Asset Management Co. Ltd.'s holdings in Waters were worth $7,947,000 at the end of the most recent reporting period.

Other institutional investors have also added to or reduced their stakes in the company. Kennebec Savings Bank bought a new position in Waters during the 3rd quarter valued at about $33,000. Ashton Thomas Securities LLC acquired a new stake in shares of Waters in the third quarter valued at $35,000. Itau Unibanco Holding S.A. bought a new position in shares of Waters in the second quarter valued at about $33,000. Blue Trust Inc. lifted its position in Waters by 190.2% during the 2nd quarter. Blue Trust Inc. now owns 119 shares of the medical instruments supplier's stock worth $35,000 after buying an additional 78 shares in the last quarter. Finally, TFC Financial Management Inc. grew its holdings in Waters by 19,900.0% during the 2nd quarter. TFC Financial Management Inc. now owns 200 shares of the medical instruments supplier's stock worth $58,000 after acquiring an additional 199 shares during the last quarter. 94.01% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several analysts have recently commented on WAT shares. Bank of America increased their price target on shares of Waters from $400.00 to $430.00 and gave the company a "neutral" rating in a research note on Friday. Sanford C. Bernstein raised their price target on Waters from $345.00 to $360.00 and gave the company a "market perform" rating in a report on Monday, November 4th. Barclays upped their target price on shares of Waters from $330.00 to $360.00 and gave the company an "underweight" rating in a research report on Monday, November 4th. Evercore ISI boosted their target price on Waters from $335.00 to $355.00 and gave the company an "in-line" rating in a research note on Tuesday, October 1st. Finally, JPMorgan Chase & Co. increased their target price on Waters from $340.00 to $380.00 and gave the stock a "neutral" rating in a research note on Monday, November 4th. One research analyst has rated the stock with a sell rating, ten have given a hold rating, three have assigned a buy rating and one has given a strong buy rating to the company's stock. Based on data from MarketBeat.com, Waters has a consensus rating of "Hold" and a consensus target price of $375.85.

Check Out Our Latest Analysis on WAT

Waters Stock Performance

Shares of NYSE WAT traded down $4.65 during trading hours on Friday, reaching $378.38. 307,928 shares of the stock were exchanged, compared to its average volume of 439,973. The company has a debt-to-equity ratio of 1.14, a quick ratio of 1.38 and a current ratio of 2.02. The stock's fifty day simple moving average is $365.52 and its 200 day simple moving average is $335.79. Waters Co. has a 52 week low of $279.24 and a 52 week high of $397.02. The firm has a market capitalization of $22.47 billion, a price-to-earnings ratio of 35.90, a P/E/G ratio of 7.05 and a beta of 1.01.

Waters (NYSE:WAT - Get Free Report) last announced its earnings results on Friday, November 1st. The medical instruments supplier reported $2.93 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $2.68 by $0.25. The firm had revenue of $740.30 million for the quarter, compared to analyst estimates of $712.99 million. Waters had a net margin of 21.43% and a return on equity of 49.93%. The business's revenue was up 4.0% compared to the same quarter last year. During the same quarter in the prior year, the business posted $2.84 EPS. Sell-side analysts predict that Waters Co. will post 11.79 EPS for the current year.

Waters Company Profile

(Free Report)

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.

Featured Stories

Institutional Ownership by Quarter for Waters (NYSE:WAT)

Should you invest $1,000 in Waters right now?

Before you consider Waters, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Waters wasn't on the list.

While Waters currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Why Meta Is Still a Top Stock Pick for 2025

Why Meta Is Still a Top Stock Pick for 2025

Meta Platforms continues to shine as one of the strongest AI-driven companies heading into 2025. Learn why Meta is a solid pick for next year.

Related Videos

Meta Platforms Tops Most Upgraded Stocks List—Here’s What to Expect
Alphabet Gaining Momentum: Can It Reach $200 by December?
3 Momentum Stock Picks With Room to Run

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines